MedAvail Holdings, Inc.
MedAvail Holdings, Inc. (MDVL) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mdvl · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for MedAvail Holdings, Inc. (MDVL) measures how much investors pay for each dollar of the company's trailing earnings. MDVL's current PE ratio of N/A is calculated by dividing its stock price of $1.80 by its TTM earnings per share of -$36.20.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2007 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Pharmaceuticals · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
MedAvail Holdings, Inc.You MDVL | $3M | N/A | — | -$36.20 |
 Affimed N.V. AFMD | $3M | N/A | — | -$7.09 |
 Aravive, Inc. ARAV | $3M | N/A | — | -$2.22 |
 Aspira Women's Health Inc. AWH | $2M | N/A | — | -$0.37 |
 Biophytis S.A. BPTS | $3M | N/A | — | -$12.55 |
 DermTech, Inc. DMTKQ | $0M | N/A | — | -$3.09 |
 Eiger BioPharmaceuticals, Inc. EIGRQ | $13M | N/A | — | -$50.78 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-36.20 | — | |
2021-12-31 FY2021 | — | $-67.08 | — | |
2020-12-31 FY2020 | — | $-228.38 | — | |
2019-12-31 FY2019 | — | $-691.31 | — | |
2018-12-31 FY2018 | — | $-121.08 | — | |
2017-12-31 FY2017 | — | $-172.68 | — | |
2016-12-31 FY2016 | — | $-225.81 | — | |
2015-12-31 FY2015 | — | $-391.51 | — | |
2014-12-31 FY2014 | — | $-436.10 | — | |
2013-12-31 FY2013 | — | $-1926.23 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for MedAvail Holdings, Inc. (MDVL) measures how much investors pay for each dollar of the company's trailing earnings. MDVL's current PE ratio of N/A is calculated by dividing its stock price of $1.80 by its TTM earnings per share of -$36.20.
Frequently asked questions
MDVL pe ratio · 6 questionsMDVL's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.80 and TTM EPS of -$36.20. Data sourced from Financial Modeling Prep via MDVL's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MedAvail Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09